Efficacy of immune checkpoint inhibitors in different types of melanoma

Immunotherapy can be used for cutaneous, mucosal, uveal and conjunctival melanoma. Nevertheless, we cannot expect the same benefit from checkpoint inhibitors for all the types of melanoma. The different biological features can explain the variable efficacy. The main results obtained with immune chec...

Descripción completa

Detalles Bibliográficos
Autores principales: Rossi, Ernesto, Schinzari, Giovanni, Maiorano, Brigida Anna, Indellicati, Giulia, Di Stefani, Alessandro, Pagliara, Monica Maria, Fragomeni, Simona Maria, De Luca, Erika Valentina, Sammarco, Maria Grazia, Garganese, Giorgia, Galli, Jacopo, Blasi, Maria Antonietta, Paludetti, Gaetano, Scambia, Giovanni, Peris, Ketty, Tortora, Giampaolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7872095/
https://www.ncbi.nlm.nih.gov/pubmed/32663057
http://dx.doi.org/10.1080/21645515.2020.1771986

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7872095/
https://www.ncbi.nlm.nih.gov/pubmed/32663057
http://dx.doi.org/10.1080/21645515.2020.1771986

Ejemplares similares